102641
A long-acting oxytocin analogue used to promote expulsion of cleansings and milk let down in fresh-calved cows. Cow: • Uterine atony during the puerperal period • Placental retention as a consequence of uterine atony • Initiation of milk ejection in stress-induced agalactia or in conditions requiring udder emptying Sow: • Uterine atony during the puerperal period • Supportive therapy of mastitis-metritis-agalactia (MMA-) syndrome • Initiation of milk ejection • Shortening of total parturition duration in sows: either after delivery of the first piglet or as a component of synchronisation of parturition in sows which have not farrowed 24 hours after administration of an appropriate PGF2α (e.g. cloprostenol) not before day 113 of pregnancy. Dosage & Administration Cows: For all indications: 3.0 - 5.0ml/animal, corresponding to 0.21 - 0.35mg carbetocin/animal. Sows: For uterine atony, MMA and milk ejection 1.5 - 3.0ml/animal, corresponding to 0.105 - 0.21mg carbetocin/animal Withdrawals Meat: cattle 0 days, pigs 0 days, Milk: cattle 0 days